Filtering by:
Chronic Lymphocytic Leukemia (CLL)Top Story
Read More
February 11, 2022
Slideshow: COVID-19 Pandemic Affects the Cancer Continuum
ACS 2021 studies show how COVID-19 is affecting prevention efforts, expected cancer screening rates, treatment, quality-of-life, and research.
September 14, 2018
FDA Approves Lumoxiti (Moxetumomab Pasudotox) for Hairy Cell Leukemia
The US Food and Drug Administration (FDA) has approved Lumoxiti (moxetumomab pasudotox-tdfk) for adults with hairy cell leukemia (HCL) that did not get better with at least 2 different previous treatments or got better but then came back.
April 12, 2016
FDA Approves Venclexta (Venetoclax) for a Type of Chronic Lymphocytic Leukemia
The US Food and Drug Administration (FDA) has approved a new targeted therapy for a certain type of chronic lymphocytic leukemia (CLL).